Loxo Oncology

Loxo Oncology/Loxo@Lilly, an Eli Lilly company, is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers.

Year Established: 2013 Stock Ticker: NYSE Exchange: LLY

Locations